AAAAAA

   
Results: 1-25 | 26-37 |
Results: 26-37/37

Authors: MITRA AK THUMMEL KE KALHORN TF KHARASCH ED UNADKAT JD SLATTERY JT
Citation: Ak. Mitra et al., INHIBITION OF SULFAMETHOXAZOLE HYDROXYLAMINE FORMATION BY FLUCONAZOLEIN HUMAN LIVER-MICROSOMES AND HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 332-340

Authors: GIBBS JP CZERWINSKI M SLATTERY JT
Citation: Jp. Gibbs et al., BUSULFAN-GLUTATHIONE CONJUGATION CATALYZED BY HUMAN LIVER CYTOSOLIC GLUTATHIONE S-TRANSFERASES, Cancer research, 56(16), 1996, pp. 3678-3681

Authors: SLATTERY JT SANDERS JE BUCKNER CD SCHAFFER RL LAMBERT KW LANGER FP ANASETTI C BENSINGER WI FISHER LD APPELBAUM FR HANSEN JA
Citation: Jt. Slattery et al., GRAFT-REJECTION AND TOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION INRELATION TO BUSULFAN PHARMACOKINETICS, Bone marrow transplantation, 16(1), 1995, pp. 31-42

Authors: FINNELL RH BENNETT GD SLATTERY JT AMORE BM BAJPAI M LEVY RH
Citation: Rh. Finnell et al., EFFECT OF TREATMENT WITH PHENOBARBITAL AND STIRIPENTOL ON CARBAMAZEPINE-INDUCED TERATOGENICITY AND REACTIVE METABOLITE FORMATION, Teratology, 52(6), 1995, pp. 324-332

Authors: MITRA AK THUMMEL KE KALHORN TF KHARASCH ED UNADKAT JD SLATTERY JT
Citation: Ak. Mitra et al., METABOLISM OF DAPSONE TO ITS HYDROXYLAMINE BY CYP2E1 IN-VITRO AND IN-VIVO, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 556-566

Authors: ANDERSON JE ANASETTI C APPELBAUM FR HANSEN JA NASH RA SLATTERY JT STORB R
Citation: Je. Anderson et al., UNRELATED DONOR (URD) MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME (MDS) - ANALYSIS OF PROGNOSTIC FACTORS AND PREPARATIVE REGIMENS, Blood, 86(10), 1995, pp. 1144-1144

Authors: NOLAN CM SANDBLOM RE THUMMEL KE SLATTERY JT NELSON SD
Citation: Cm. Nolan et al., HEPATOTOXICITY ASSOCIATED WITH ACETAMINOPHEN USAGE IN PATIENTS RECEIVING MULTIPLE-DRUG THERAPY FOR TUBERCULOSIS, Chest, 105(2), 1994, pp. 408-411

Authors: THOMPSON JA BIANCO JA BENYUNES MC NEUBAUER MA SLATTERY JT FEFER A
Citation: Ja. Thompson et al., PHASE IB TRIAL OF PENTOXIFYLLINE AND CIPROFLOXACIN IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY FOR METASTATIC RENAL-CELL CARCINOMA, Cancer research, 54(13), 1994, pp. 3436-3441

Authors: ZAND R NELSON SD SLATTERY JT THUMMEL KE KALHORN TF ADAMS SP WRIGHT JM
Citation: R. Zand et al., INHIBITION AND INDUCTION OF CYTOCHROME P4502E1-CATALYZED OXIDATION BYISONIAZID IN HUMANS, Clinical pharmacology and therapeutics, 54(2), 1993, pp. 142-149

Authors: CLIFT RA BIANCO JA APPELBAUM FR BUCKNER CD SINGER JW BAKKE L BENSINGER WI BOWDEN RA MCDONALD GB SCHUBERT M SHIELDS AF SLATTERY JT STORB R FISHER LD MORI M THOMAS ED HANSEN JA
Citation: Ra. Clift et al., A RANDOMIZED CONTROLLED TRIAL OF PENTOXIFYLLINE FOR THE PREVENTION OFREGIMEN-RELATED TOXICITIES IN PATIENTS UNDERGOING ALLOGENEIC MARROW TRANSPLANTATION, Blood, 82(7), 1993, pp. 2025-2030

Authors: THUMMEL KE LEE CA KUNZE KL NELSON SD SLATTERY JT
Citation: Ke. Thummel et al., OXIDATION OF ACETAMINOPHEN TO N-ACETYL-P-AMINOBENZOQUINONE IMINE BY HUMAN CYP3A4, Biochemical pharmacology, 45(8), 1993, pp. 1563-1569

Authors: LYNN AM NESPECA MK OPHEIM KE SLATTERY JT
Citation: Am. Lynn et al., RESPIRATORY EFFECTS OF INTRAVENOUS MORPHINE INFUSIONS IN NEONATES, INFANTS, AND CHILDREN AFTER CARDIAC-SURGERY, Anesthesia and analgesia, 77(4), 1993, pp. 695-701
Risultati: 1-25 | 26-37 |